Condition
bvFTD
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Recruiting1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05742698Phase 2Terminated
Nabilone for Agitation in Frontotemporal Dementia
NCT07316413Not ApplicableRecruiting
Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration
NCT05917886Not ApplicableCompleted
Auditory Beat Stimulation and Behavioural Variant of Frontotemporal Dementia
Showing all 3 trials